9 months ago
Novavax COVID vaccine heads to U.S. FDA advisory committee
Advisers to the U.S. Food and Drug Administration on Tuesday will consider whether to recommend Novavax Inc's (NVAX.O) COVID-19 vaccine for adults, which the drugmaker hopes can become the shot of choice among some American vaccine skeptics. Novavax's shot is a more traditional type of vaccine employing technology that has been used for decades to combat diseases including Hepatitis B and influenza.
Continue Reading
https://www.reuters.com
Join the Discussion